Merit Medical Systems EBIT 2010-2024 | MMSI

Merit Medical Systems annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Merit Medical Systems EBIT for the quarter ending September 30, 2024 was $0.037B, a 6.04% increase year-over-year.
  • Merit Medical Systems EBIT for the twelve months ending September 30, 2024 was $0.153B, a 26.49% increase year-over-year.
  • Merit Medical Systems 2023 annual EBIT was $0.124B, a 41.55% increase from 2022.
  • Merit Medical Systems 2022 annual EBIT was $0.088B, a 43.74% increase from 2021.
  • Merit Medical Systems 2021 annual EBIT was $0.061B, a 3999.87% decline from 2020.
Merit Medical Systems Annual EBIT
(Millions of US $)
2023 $124
2022 $88
2021 $61
2020 $-2
2019 $15
2018 $59
2017 $33
2016 $35
2015 $38
2014 $40
2013 $28
2012 $30
2011 $33
2010 $17
2009 $33
Merit Medical Systems Quarterly EBIT
(Millions of US $)
2024-09-30 $37
2024-06-30 $46
2024-03-31 $36
2023-12-31 $34
2023-09-30 $35
2023-06-30 $29
2023-03-31 $26
2022-12-31 $30
2022-09-30 $19
2022-06-30 $23
2022-03-31 $15
2021-12-31 $22
2021-09-30 $16
2021-06-30 $9
2021-03-31 $14
2020-12-31 $16
2020-09-30 $0
2020-06-30 $-19
2020-03-31 $1
2019-12-31 $-3
2019-09-30 $-3
2019-06-30 $12
2019-03-31 $10
2018-12-31 $14
2018-09-30 $21
2018-06-30 $15
2018-03-31 $9
2017-12-31 $13
2017-09-30 $1
2017-06-30 $13
2017-03-31 $6
2016-12-31 $13
2016-09-30 $3
2016-06-30 $12
2016-03-31 $8
2015-12-31 $8
2015-09-30 $9
2015-06-30 $12
2015-03-31 $9
2014-12-31 $14
2014-09-30 $12
2014-06-30 $7
2014-03-31 $6
2013-12-31 $11
2013-09-30 $8
2013-06-30 $7
2013-03-31 $2
2012-12-31 $4
2012-09-30 $9
2012-06-30 $8
2012-03-31 $8
2011-12-31 $6
2011-09-30 $7
2011-06-30 $11
2011-03-31 $10
2010-12-31 $6
2010-09-30 $-3
2010-06-30 $9
2010-03-31 $6
2009-12-31 $8
2009-09-30 $8
2009-06-30 $9
2009-03-31 $8
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $6.102B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36